Related changes
Jump to navigation
Jump to search
Enter a page name to see changes on pages linked to or from that page. (To see members of a category, enter Category:Name of category). Changes to pages on your Watchlist are in bold.
List of abbreviations:
- N
- This edit created a new page (also see list of new pages)
- m
- This is a minor edit
- b
- This edit was performed by a bot
- (±123)
- The page size changed by this number of bytes
1 July 2024
m 00:49 | Atezolizumab (Tecentriq) diffhist +2 Warner-admin talk contribs Text replacement - "http://www.gene.com/" to "https://www.gene.com/" |
m 00:49 | Bevacizumab (Avastin) diffhist +3 Warner-admin talk contribs Text replacement - "http://www.gene.com/" to "https://www.gene.com/" |
m 00:49 | Erlotinib (Tarceva) diffhist +2 Warner-admin talk contribs Text replacement - "http://www.gene.com/" to "https://www.gene.com/" |
m 00:49 | Alectinib (Alecensa) diffhist +2 Warner-admin talk contribs Text replacement - "http://www.gene.com/" to "https://www.gene.com/" |
26 June 2024
m 01:42 | Trametinib (Mekinist) diffhist +2 Warner-admin talk contribs Text replacement - "http://en.wikipedia.org" to "https://en.wikipedia.org" |
25 June 2024
21 June 2024
m 23:48 | Bevacizumab-adcd (Vegzelga) diffhist +10 Jwarner talk contribs →Also known as |
m 23:47 | Bevacizumab-maly (Alymsys) diffhist +9 Jwarner talk contribs →Also known as |
N 23:42 | Bevacizumab-tnjn (Avzivi) diffhist +4,211 Jwarner talk contribs Created page with "'''Note: this is an FDA-approved biosimilar. The information below is reproduced from the Bevacizumab (Avastin) page, except for the details of FDA indication and the refe..." |
18 June 2024
|
m 14:08 | Crizotinib (Xalkori) 2 changes history +20 [Jwarner (2×)] | |||
m |
|
14:08 (cur | prev) +11 Jwarner talk contribs →Also known as | |||
m |
|
14:07 (cur | prev) +9 Jwarner talk contribs →Also known as |
|
m 10:54 | Pembrolizumab (Keytruda) 2 changes history +220 [Jwarner (2×)] | |||
m |
|
10:54 (cur | prev) -2 Jwarner talk contribs | |||
m |
|
10:53 (cur | prev) +222 Jwarner talk contribs →Endometrial cancer |
15 June 2024
|
m 00:29 | Durvalumab (Imfinzi) 3 changes history +314 [Jwarner (3×)] | |||
m |
|
00:29 (cur | prev) 0 Jwarner talk contribs | |||
m |
|
00:27 (cur | prev) +53 Jwarner talk contribs | |||
m |
|
00:25 (cur | prev) +261 Jwarner talk contribs →History of changes in FDA indication |
13 June 2024
m 21:26 | Repotrectinib (Augtyro) diffhist +444 Jwarner talk contribs →History of changes in FDA indication |
12 June 2024
m 23:00 | Selpercatinib (Retevmo) diffhist +354 Jwarner talk contribs →Thyroid cancer |
11 June 2024
m 14:34 | Gefitinib (Iressa) diffhist +9 Jwarner talk contribs →Also known as |
|
m 14:23 | Erlotinib (Tarceva) 7 changes history +65 [Jwarner (7×)] | |||
m |
|
14:23 (cur | prev) +9 Jwarner talk contribs →Also known as | |||
m |
|
14:23 (cur | prev) +10 Jwarner talk contribs →Also known as | |||
m |
|
14:23 (cur | prev) +11 Jwarner talk contribs →Also known as | |||
m |
|
14:22 (cur | prev) +10 Jwarner talk contribs →Also known as | |||
m |
|
14:22 (cur | prev) +8 Jwarner talk contribs →Also known as | |||
m |
|
14:21 (cur | prev) +8 Jwarner talk contribs →Also known as | |||
m |
|
14:21 (cur | prev) +9 Jwarner talk contribs →Also known as |
1 June 2024
|
m 04:07 | Trametinib (Mekinist) 2 changes history +461 [Jwarner (2×)] | |||
m |
|
04:07 (cur | prev) +70 Jwarner talk contribs | |||
m |
|
04:06 (cur | prev) +391 Jwarner talk contribs →History of changes in PMDA indication |
|
m 04:06 | Dabrafenib (Tafinlar) 2 changes history +461 [Jwarner (2×)] | |||
m |
|
04:06 (cur | prev) +70 Jwarner talk contribs | |||
m |
|
04:05 (cur | prev) +391 Jwarner talk contribs →History of changes in PMDA indication |
m 04:03 | Nivolumab (Opdivo) diffhist +210 Jwarner talk contribs →Malignant pleural mesothelioma |
m 03:52 | Trastuzumab deruxtecan (Enhertu) diffhist +336 Jwarner talk contribs |
m 03:50 | Pembrolizumab (Keytruda) diffhist +203 Jwarner talk contribs →Renal cell carcinoma |